ANWPX
Price
$75.17
Change
-$0.11 (-0.15%)
Updated
Jun 22 closing price
Net Assets
171.51B
CIGEX
Price
$21.96
Change
+$0.09 (+0.41%)
Updated
Jun 22 closing price
Net Assets
204.55M
Interact to see
Advertisement

ANWPX vs CIGEX

ANWPX vs CIGEX Comparison Chart in %
View a ticker or compare two or three
VS
ANWPX vs. CIGEX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANWPX is a Hold and CIGEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ANWPX has more cash in the bank: 172B vs. CIGEX (205M). ANWPX pays higher dividends than CIGEX: ANWPX (0.96) vs CIGEX (0.00). ANWPX was incepted earlier than CIGEX: ANWPX (53 years) vs CIGEX (19 years). CIGEX (1.25) is less costly to investors than ANWPX (0.71). CIGEX is a more actively managed with annual turnover of: 114.00 vs. ANWPX (23.00). ANWPX has a lower initial minimum investment than CIGEX: ANWPX (250) vs CIGEX (1000000). CIGEX annual gain was more profitable for investors over the last year : 17.83 vs. ANWPX (13.44). CIGEX return over 5 years is better than : 23.12 vs. ANWPX (16.37).
ANWPXCIGEXANWPX / CIGEX
Total Expense Ratio0.711.1562%
Annual Report Gross Expense Ratio0.711.2557%
Fund Existence53 years19 years-
Gain YTD6.45821.63530%
Front Load6%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets172B205M83,902%
Annual Yield % from dividends0.960.00-
Returns for 1 year13.4417.8375%
Returns for 3 years42.0164.1066%
Returns for 5 years16.3723.1271%
Returns for 10 years124.9982.77151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETHT9.140.28
+3.16%
Proshares Ultra Ether ETF
SEMI40.720.14
+0.34%
Columbia Select Technology ETF
IMRA17.23N/A
N/A
Bitwise MARA Option Income Strategy ETF
JSI51.27-0.07
-0.14%
Janus Henderson Securitized Income ETF
BTAL10.92-0.04
-0.36%
AGF U.S. Market Neutral Anti-Beta